CIMC study plan

Map the CIMC exam blueprint weightings to a personal mastery checklist, flagging every subtopic in Domains 1 and 2 as known, shaky, or unknown

Draft a one-page comparison of the roles and decision rights of sponsor, CRO, principal investigator, and clinical research coordinator across a trial lifecycle

Build a timeline of the major global regulatory submission pathways (US IND, EU CTR, and one additional region) noting which artifacts each requires

Write five leadership scenarios (e.g., underperforming site, conflicting functional priorities) and record your chosen intervention plus rationale

Summarize the core obligations of ICH E6 Good Clinical Practice and identify which responsibilities sit with sponsor versus investigator

Explain the purpose and required contents of an investigator's brochure and how it drives protocol and consent design

Outline the essential elements of a regulatory inspection readiness program and list the records most commonly requested

Draft an escalation memo describing how you would handle a discovered deviation from a regulatory submission commitment

Deconstruct a protocol synopsis into its design components: objectives, endpoints, population, randomization, and analysis intent

Construct a feasibility assessment framework covering site capability, patient pool, competing trials, and enrollment rate assumptions

Sequence the study start-up activities from site identification through site activation and identify the critical-path dependencies

Draft the key contents of a site initiation visit agenda and explain the purpose of each item

Differentiate monitoring approaches (on-site, centralized, risk-based) and justify a chosen mix for a given risk profile

Build a monitoring plan outline that links critical data and processes to verification activities

Design a source data verification sampling strategy and state its limitations

Practice converting a protocol ambiguity into a clarified, monitorable requirement

Trace the data flow from source capture through entry, query resolution, and database lock

Explain how protocol endpoints map to analysis populations and why the mapping matters for interpretation

Identify the quality metrics and key risk indicators a sponsor would track to detect site or data drift

Draft a corrective and preventive action plan for a recurring data discrepancy pattern

Distinguish serious adverse events, adverse events, and suspected unexpected serious adverse reactions and state the reporting clock for each

Outline the informed consent process from pre-screening discussion through documentation and re-consent triggers

Explain the roles of an institutional review board or ethics committee in initial and continuing review

Draft a safety narrative for a hypothetical serious adverse event using the standard required elements

Build a study budget structure separating pass-through costs from site service fees and identify common omission risks

Explain the purpose and typical structure of a clinical trial agreement and a vendor master services agreement

Describe how change orders and out-of-scope work are identified, priced, and approved

Apply human subject protection principles to a scenario involving vulnerable populations or payment for participation

Re-run the week 1 self-assessment and confirm every subtopic is at mastery or has a remediation note

Complete a timed mixed-domain practice set and categorize every miss by root cause (knowledge gap, misread, or reasoning error)

Synthesize cross-domain linkages (e.g., how a safety signal flows into monitoring, data, and regulatory reporting) into a single reference map

Write a final-week review schedule targeting only the remaining weak areas